BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a report published on Saturday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Up 3.8 %

Shares of BIOL stock opened at $0.01 on Friday. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.03. The company has a market cap of $315,696.15, a PE ratio of 0.00 and a beta of 0.67.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.